simultaneously bound both 12SI-TSP and "'I-P, confirming trmolecular complex formation. Rocket immunoelectrophoresis of mixtures of the purified radiolabeled proteins into anti-Pig containing agarose also confirmed trimolecular complex formation. The TSP-HRGP-PIg complex bound a similar amount of heparin as the TSP-HRGP complex, demonstrating that the HRGP within the trimolecular complex maintained functional capability. Similarly, using a fluorometric plasmin substrate, the trmolecular complex was shown to be an effective substrate for tissue plasminogen activator. Significant amounts of plasmin were generated from the TSP-HRGP-Plg complex (equivalent to that from the TSP-Pig complex), but the rate of plasmin generation from the trimolecular complex was greater than from the bimolecular complex, suggesting an important interaction of HRGP with Pig when both are complexed to TSP. The macromolecular assembly of these three proteins on cellular surfaces, such as the platelet, may serve important regulatory functions, both prothrombotic at sites of active fibrin deposition and proteolytic in nonfibrin-containing micro-
Introduction Thrombospondin (TSP),' a 450,000-mol wt multinodular glycoprotein (1, 2) , is a major constituent of the platelet a-granule (3, 4) and becomes surface associated upon platelet stimulation (5) . It is also a product of endothelial cells (6, 7) , fibroblasts (8) , and monocytes (9) , and is a constituent of the extracellular matrix (8) . TSP is a multifunctional molecule that appears to be organized, like fibronectin (10) , into discrete functional domains (11) (12) (13) . The endogenous lectin of human platelets is TSP (14, 15) and anti-TSP Fab partially inhibits platelet aggregation (16) , suggesting an important role in platelet function. Among other known functions of TSP are the ability to bind specifically with heparin (1, 11) , fibrinogen (17) , fibronectin (17, 18) , and type V collagen (19) , and thus, perhaps play a role in extracellular matrix organization, cellcell and cell-matrix communication, and modulation of hemostasis.
Recently we have shown that there is a high affinity interaction of TSP with histidine-rich glycoprotein (HRGP) (20) and with plasminogen (Plg) (21) . HRGP, an a2-glycoprotein of human plasma (22) , is also found in platelet a-granules and is secreted upon platelet activation (23) . It is a protein of multiple functions, including metal binding and perhaps transport (24) , immunoregulation (25), and modulation of hemostasis. HRGP binds heparin with high affinity and neutralizes its anticoagulant effect (26, 27) ; it also binds Plg via that protein's high affinity lysine-binding site (LBS) (28) and thus may serve as a physiological counterpart to the antifibrinolytic amino acids. The TSP-HRGP complex retains the heparin binding and neutralizing function of HRGP (20) , and the TSP-Pig interaction, which is also mediated via the Plg LBS, interferes with the ability of tissue plasminogen activator (TPA) to activate Plg (21) on a fibrin clot. In this paper, we report that TSP can form a trimolecular complex with HRGP and Plg and that the HRGP and Plg within the macromolecular complex retain functional capability. Such functional macromolecular complexes, when assembled on platelet as well as other cellular surfaces, may modulate thrombotic as well as fibrinolytic events.
Methods
Materials. Electrophoresis grade agarose was purchased from FMC Corp., Rockland, ME. Microtiter plates and a Titertek multiscan photometer were purchased from Flow Laboratories, McLean, VA. Heparin Sepharose CL-4B, cyanogen bromide-activated Sepharose 4B, a Mono Q anion exchange column, and a fast performance liquid chromatograph (FPLC) were purchased from Pharmacia Fine Chemicals, Piscataway, NJ. The fluorometric plasmin substrate, D-val-leulys-7-amino-4-trifluoromethyl coumarin (AFC), was Purification of other proteins. Purified human native N-terminal glutamine plasminogen (glu-Plg), plasmin, HRGP, von Willebrand Factor (VWF), and fibronectin were prepared as described in detail previously (17, 20, 21, 30 Radioisotope labeling. Purified TSP, HRGP, Plg, and fibrinogen were labeled to high specific activity with '25I using the modified chloramine T method (31) . For the Sepharose bead binding experiments, purified human albumin and TSP were labeled with '25I and Plg with '3'I using 1.5-ml polypropylene tubes (32) coated with iodogen (Pierce Chemical Co., Rockford, IL).
Antisera. Antisera to purified Plg and HRGP were raised in rabbits by standard techniques (33) as described previously (17, 20, 21 Protein binding to HRGP-linked Sepharose 4B. HRGP or human albumin, 2 mg, were covalently coupled to I ml cyanogen bromideactivated Sepharose 4B, as previously described (16) . Efficiency of coupling was >95% as determined by measuring protein concentrations of the coupling solutions before and after the cross-linking reaction. After incubating the beads in I ml of the Tris-Tween-calcium buffer containing 0.1% BSA for I h at 370C to saturate nonspecific protein binding sites, aliquots containing 3 tl of the beads were removed, washed with buffer, and incubated with 0.5 ml Tris-Tween-calcium containing either '251-TSP (4 jsg/ml; 12 X 103 cpm/jsg), '31I-Plg (12 jug/ml; 14 X 103 cpm/,ug), or both for 3 h at 370C. The beads were then washed five times with I ml of the buffer and total bound radioactivity counted in a dual channel gamma counter. The beads were then incubated with 10 mM EACA for 2 h at 370C and the eluted material counted. Nonspecific binding was defined as the amount of '251-TSP and/or '3'1-Plg bound to the same volume of albumin-coupled beads. The binding of '251-albumin (12 ug/ml; 14 X 103 cpm/jug) to the HRGP beads was also determined as another measure of specificity. In those experiments, the buffer contained 5% nonfat dry milk instead of BSA. In all experiments, the washing steps were done by low speed centrifugation (900 g) through a porous filter. All experiments were done in triplicate.
Rocket immunoelectrophoresis. Agarose stocks were prepared by melting electrophoresis grade agarose in 0.05 M phosphate buffer, pH 7.4, at a concentration of 1%. The melted agarose was cooled to 45°C and mixed with prewarmed monospecific anti-Plg antiserum (final concentration, 0.08%). 3-5 ml of this antibody-agarose mixture was layered onto glass microscope slides and antigen samples consisting of either TSP, Plg, HRGP, or combinations thereof were applied in 20 mM Tris-HCI, 0.15 M NaCl, 1.5 mM CaCI2, pHI 7.4, to 4-mm diam wells. The individual slides were subjected to 50 V and 3 mA for 20 h at 22°C. Following electrophoresis, the slides were washed exhaustively with saline containing 0.1% azide followed by 30-min distilled water wash, dried, and stained with 1% amido black in 40% ethanol/10% acetic acid and destained in 90% methanol/5% acetic acid. For all studies, the amount of Plg was held constant and for the mixture studies, the mole ratios were fixed at 3:3:1 for Plg/HRGP/TSP. Fluorometric plasmin assay. To TSP adsorbed on plastic microtiter wells (as in ELISA studies) was added mixtures of Plg and HRGP in the Tris-Tween-calcium buffer. After washing away unbound ligands, 0.3 ml of substrate buffer was added containing 10 AiM D-val-leu-lys-AFC and 5 U/ml TPA (in the same Tris-Tween-calcium). At timed intervals, well contents were removed and substrate hydrolysis measured at excitation of 400 nm and emission of 505 nm. The increase of fluorescence, measured as relative fluorescence units (RFU), was parabolic with time conforming to the equation for rectilinear motion with constant acceleration (35) . The relative initial rates of plasmin generation, which are directly proportional to the acceleration, were determined according to the method of Kosow et Beads (3 zd) were incubated with '25I-TSP (2 jg) and/or '3'I-Plg (6 ,ug) for 3 h at 37°C, washed five times in buffer, and then counted in a dual channel gamma counter to quantitate bound material. After counting, they were incubated in 10 mM EACA for 2 h at 37°C and then, the eluate was counted.
were co-incubated with '251-TSP and '3'I-Plg, both ligands simultaneously bound, demonstrating trimolecular complex formation. As in the ELISA, no inhibition of one ligand toward the other was seen. EACA (10 mM) eluted 90% of the bound Plg from the HRGP-Plg complexes but only 12.4% of the bound TSP from the HRGP-TSP complexes. EACA, however, eluted 42.6% of the TSP from the trimolecular HRGP-Plg-TSP complexes; i.e., there appeared to be two pools of TSP within these trimolecular complexes, an EACA elutable pool and an EACA nonelutable pool (P < 0.05).
Demonstration of TSP-Plg-HRGP complex formation by rocket immunoelectrophoresis. Another system was devised to study trimolecular complex formation based on immunoprecipitation in agar (38, 21) . Rocket immunoelectrophoresis of mixtures of the three proteins (TSP, Plg, and HRGP) into anti-Plg containing agar was performed. As we have previously reported (21) , radiolabeled Plg mixed with TSP (molar ratio, 3:1) and electrophoresed into anti-Plg-containing agar migrated more rapidly than Plg alone and formed an anodally moving, sharp peak that contained Plg as detected both by immunoprecipitation with specific antibody and by autoradiography (Fig. 3, wells 1 and 2) . We have shown previously that radiolabeled TSP was also demonstrable in this rapidly moving anodal immunoprecipitin arc (21); i.e., a bimolecular TSP-Plg complex was immunoprecipitated. We now show that when HRGP was included in the TSP-Plg mixture the same rapidly moving anodal Plg arc was formed (Fig. 3, well 3 ). To demonstrate that this immunoprecipitin arc contained the individual constituents of the trimolecular complex, studies were performed in which each of the ligands was separately radiolabeled. Fig. 4, wells 2, 3, and 4 show an autoradiograph of such a study. Each of these three wells contained the same molar ratio of TSP:HRGP:Plg (1:3:3), but in well 2 the Plg was labeled, in well 3 the TSP was labeled, and in well 4 the HRGP was labeled. All three arcs were radioactive demonstrating that all three proteins (i.e., a trimolecular complex) were immunoprecipitated by the anti-Pig antibody agar. TSP or HRGP alone or the TSP-HRGP complex, as expected, were not precipitated in the anti-Plg agar. The bimolecular Plg-HRGP complex was detected by this system (Fig. 4, well 5 ) and could easily be distinguished from the trimolecular TSPPlg-HRGP complex because its mobility was slightly decreased compared with Plg alone. We have previously shown that Plg mixed with albumin, gammaglobulin, or factor VIII-related antigen (VIIIR:Ag) at similar molar ratios to that employed with TSP showed no alteration in mobility by rocket immunoelectrophoresis (21) .
Functionality of the TSP-HRGP-Plg complex. To examine whether Plg and HRGP retained functional capability as part of a trimolecular complex with TSP, we studied the ability of the complex to bind heparin (a function of HRGP) and to serve as a substrate for plasmin generation by the action of TPA (a function of Plg). Complexes of TSP with saturating amounts of Plg, HRGP, or both together were prepared on microtiter plates as described above and either incubated with 35S-heparin to quantify heparin binding or with TPA and a fluorometric plasmin substrate to quantify plasmin generation.
The TSP-HRGP-Plg complex bound equivalent amounts of heparin as the TSP-HRGP complex (0.83 ng/well) and more than TSP alone or the TSP-Plg complex (Table III) , demonstrating that HRGP retained functional capacity within the trimolecular complex. TPA (5 U/ml) generated significant amounts of plasmin from the TSP-Pig complex (Fig. 5) . No plasmin was generated from the TSP-HRGP complex and only minimal amounts from Plg added to other adsorbed proteins (fibronectin and VWF). The amount of plasmin generated from the TSP-Plg-HRGP complex was equivalent to that from the TSP-Plg complex, demonstrating that Plg retained functional capacity within the trimolecular complex. When the complexes (either TSP-Plg or TSP-HRGP-Plg) were saturated with Plg, 2.6 ng of plasmin was generated (Fig. 5) . This represents an activation of '20% of the bound Plg (determined from '251I-Plg binding studies). When the complexes were activated by 20 U/ml streptokinase (data not shown), similar amounts of plasmin were generated. At all concentrations of Plg tested (up to 100 nM) and all concentrations of HRGP tested (10- the left (Fig. 6 ). When the complex was saturated with HRGP (50 nM HRGP), the relative initial reaction rate was increased by 1.8-fold at 4 ug/ml Plg and 1.6-fold at 8 gg/ml Plg. These increases were found to be significant at P < 0.025 using a two-way analysis of variance.
Kinetic parameters were obtained to demonstrate the ability of TSP to promote Pig activation by TPA. Initial reaction rates were calculated as described above on TSP-coated microtiter wells and Lineweaver-Burke transformations plotted using a least squares linear regression estimation. These data (Table  IV) show that compared with fluid phase, the Michaelis constant (KM) of activation is markedly decreased, so that even though the catalytic rate constant (kai) is only minimally increased, the overall catalytic efficiency (kjKM) is increased by 35-fold. At physiological Pig concentrations (-2 gM), complete saturation would occur at this KM. (20) . In addition,
we have recently shown that TSP can also bind specifically with Plg and that this interaction, which is mediated by the (Fig. 2) . Neither ligand (21) . We have now shown that when radiolabeled HRGP was included in the TSP-Plg mixture and similarly electrophoresed, radioactivity was detected in the rapid peak (Fig. 4) , demonstrating a trimolecular complex.
These studies do not permit accurate measurement of stoichiometric relations. Previously, however, we showed, by using sucrose density ultracentrifugation, that the stoichiometry of the TSP-HRGP complex was -3.5 HRGP molecules/ molecule of TSP (20) . ELISA studies using TSP monomer showed comparable extent of bimolecular and trimolecular complex formation with HRGP and Pig compared with whole TSP, suggesting that the unit of binding is the TSP monomer and that each TSP molecule may bind three HRGP and three Plg molecules.
To examine whether the trimolecular TSP-HRGP-Plg complex retained functional capability, we studied the ability of the complex to bind heparin (a function of HRGP) and to serve as a substrate for plasmin generation by TPA. Table II shows, using a 35S-heparin probe, that the trimolecular complex retained the heparin-binding capacity of the bimolecular TSP-HRGP complex and that it bound significantly more heparin than TSP alone.
Using a fluorometric plasmin substrate (D-val-leu-lys-AFC), we have demonstrated that significant amounts of plasmin were generated by TPA from both the bimolecular TSP-Plg and the trimolecular TSP-Plg-HRGP complexes compared with Plg added to fibronectin or VWF-coated microtiter wells (Fig. 5) . Interestingly, plasmin was generated from the trimolecular complex at a more rapid rate than from the TSP-Plg bimolecular complex (Fig. 6) Because fibrin is the most important positive modulator of TPA (37), a kinetic analysis was done to compare fibrin and TSP in their ability to promote Plg conversion to plasmin by TPA (Table IV) . The fibrin kinetics were obtained using a '25I-fibrin plate assay (21) . The TSP study was done in a nonfibrin system using a fluorometric plasmin substrate under otherwise similar experimental conditions; i.e., activation was measured in polystyrene wells coated with a film of protein (4 Mg/ml TSP or 6.5 jug/ml clotted fibrinogen). Like fibrin, TSP markedly decreased the KM of activation compared with that in fluid phase; i.e., the TSP-Plg complex compared favorably to the fibrin-Plg complex in affinity for TPA (0.085 vs. 0.10 IAM).
The overall catalytic efficiency (k,,nKM) in the presence of TSP was increased thus by 35-fold compared with fluid phase, while that in the presence of fibrin was increased 400-fold. This difference between TSP and fibrin was due to the additional effect of fibrin of a 15-fold increase in kat. Thus, compared with fluid phase, the solid phase TSP-Plg interaction resulted in a 40-fold increase in reaction rate, which was approximately 10-fold less than that seen on a fibrin surface. We conclude that fibrin is a more efficient surface for Plg activation than TSP.
The physiological significance of the TSP-HRGP-Plg trimolecular complex is thus complicated and remains to be fully clarified. We previously raised the possibility that TSP on the activated platelet surface may regulate heparin action by binding HRGP (20) . Since TSP also binds Plg and inhibits its activation by TPA on a fibrin clot (21), we have speculated that localization of Plg on the activated platelet surface may play a role in modulating fibrinolysis in the microenvironment of the platelet plug. Thus, in a focal region of active hemostasis, the sum total of these molecular associations would be prothrombotic, leading to increased deposition of fibrin.
The data presented in this paper also suggest that TSP itself can serve as an alternative "surface," other than fibrin, for TPA-induced Plg activation and that this effect is augmented by the inclusion of HRGP within the complex. In view of the broad distribution of TSP in different cell systems, including endothelial cells (6) , smooth muscle cells (7, 40) , fibroblasts (8) , and monocytes (9) , as well as the extracellular matrix (8), it seems reasonable that the TSP-HRGP-Plg complex could assemble in focal areas independent of the presence of fibrin. At sites of inflammation, tumor cell migration, and implantation as well as trophoblast implantation, TPA synthesis and secretion are known to be increased (41) (42) (43) (44) . Thus, Plg immobilized on TSP at such sites could generate plasmin in a fibrin-free environment in a kinetically favorable manner. It is thus likely that the TSP-HRGP-Plg macromolecular complex may effect different physiological endpoints in different microenvironments.
